Feasibility of a Geriatric Assessment to Detect and Quantify Sarcopenia and Physical Functioning in German Nursing Home Residents-A Pilot Study.
nursing home
physical functioning
prevalence
sarcopenia
Journal
Geriatrics (Basel, Switzerland)
ISSN: 2308-3417
Titre abrégé: Geriatrics (Basel)
Pays: Switzerland
ID NLM: 101704019
Informations de publication
Date de publication:
02 Jul 2021
02 Jul 2021
Historique:
received:
19
06
2021
revised:
27
06
2021
accepted:
01
07
2021
entrez:
21
7
2021
pubmed:
22
7
2021
medline:
22
7
2021
Statut:
epublish
Résumé
Entering into a nursing home leads to increased immobility and further reductions in physical and cognitive functioning. As a result, there is a risk of sarcopenia, which is characterized by loss of muscle strength, muscle mass and physical functioning. To our knowledge, the feasibility of sarcopenia screening has not yet been performed in the German nursing home setting. For sarcopenia screening, the specifications of EWGSOP2 were applied. The quantification of sarcopenia was performed according to the corresponding cut-off values. The collection of anthropometric data and the morbidity status were recorded. SARC-F, mini-mental state examination, Barthel Index, Short Physical Performance Battery and Timed Up and Go tests were implemented. In one participant, severe sarcopenia could be identified. The quantification was not possible for four participants. A suspicion of sarcopenia was not confirmed in five participants. Only one person was able to perform all assessments. Sarcopenia screening according to EWGSOP2 presented satisfactory feasibility by nursing home residents. However, further tests to assess the physical functioning of the participants often could not be performed. Moreover, inconsistencies in individual assessments became apparent, leading to inconclusive analyses. The recording of sarcopenia prevalence in German nursing homes should be the goal of further research.
Sections du résumé
BACKGROUND
BACKGROUND
Entering into a nursing home leads to increased immobility and further reductions in physical and cognitive functioning. As a result, there is a risk of sarcopenia, which is characterized by loss of muscle strength, muscle mass and physical functioning. To our knowledge, the feasibility of sarcopenia screening has not yet been performed in the German nursing home setting.
METHODS
METHODS
For sarcopenia screening, the specifications of EWGSOP2 were applied. The quantification of sarcopenia was performed according to the corresponding cut-off values. The collection of anthropometric data and the morbidity status were recorded. SARC-F, mini-mental state examination, Barthel Index, Short Physical Performance Battery and Timed Up and Go tests were implemented.
RESULTS
RESULTS
In one participant, severe sarcopenia could be identified. The quantification was not possible for four participants. A suspicion of sarcopenia was not confirmed in five participants. Only one person was able to perform all assessments.
CONCLUSIONS
CONCLUSIONS
Sarcopenia screening according to EWGSOP2 presented satisfactory feasibility by nursing home residents. However, further tests to assess the physical functioning of the participants often could not be performed. Moreover, inconsistencies in individual assessments became apparent, leading to inconclusive analyses. The recording of sarcopenia prevalence in German nursing homes should be the goal of further research.
Identifiants
pubmed: 34287326
pii: geriatrics6030069
doi: 10.3390/geriatrics6030069
pmc: PMC8293077
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Bundesministerium für Gesundheit
ID : ZMVI1-2519FSB114
Références
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
Geriatr Gerontol Int. 2017 Jul;17(7):1118-1124
pubmed: 27436345
Gerontol Geriatr Med. 2016 Mar 16;2:2333721416637798
pubmed: 28138492
J Nutr Health Aging. 2017;21(7):825-829
pubmed: 28717813
Maturitas. 2015 Dec;82(4):418-23
pubmed: 26341045
J Neurol Sci. 2010 Jul 15;294(1-2):102-6
pubmed: 20444477
Clin Nutr ESPEN. 2018 Oct;27:113-119
pubmed: 30144883
J Nutr Health Aging. 2020;24(1):83-90
pubmed: 31886813
Age Ageing. 2011 Jul;40(4):423-9
pubmed: 21624928
Pflege. 2012 Dec;25(6):411-25
pubmed: 23188752
BMJ Open. 2018 Nov 12;8(11):e021252
pubmed: 30420343
J Am Geriatr Soc. 1991 Feb;39(2):142-8
pubmed: 1991946
Clin Nutr. 2015 Aug;34(4):667-73
pubmed: 25103151
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Aug;56(8):1040-7
pubmed: 23884518
Aging Clin Exp Res. 2019 Jul;31(7):951-959
pubmed: 30218406
J Gerontol A Biol Sci Med Sci. 2012 Jan;67(1):48-55
pubmed: 21393423
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
BMC Geriatr. 2020 Nov 10;20(1):461
pubmed: 33172391
J Musculoskelet Neuronal Interact. 2017 Sep 1;17(3):209-217
pubmed: 28860423
Biomed Res Int. 2015;2015:891390
pubmed: 26640800
Age Ageing. 2019 Sep 1;48(5):719-724
pubmed: 31112221
J Am Med Dir Assoc. 2013 Aug;14(8):531-2
pubmed: 23810110
J Diabetes Metab Disord. 2017 May 16;16:21
pubmed: 28523252